Needle injection trial aims to heal parasitic skin sores
NCT ID NCT06797544
Summary
This study is testing whether injecting an antibiotic called levofloxacin directly into skin lesions can treat cutaneous leishmaniasis, a parasitic skin infection. The trial will involve 40 participants with up to six lesions each, who will receive weekly injections for up to six weeks. Researchers will track how well the lesions heal over 90 days to see if this local treatment is effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LEISHMANIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mustansiriyah University
RECRUITINGBaghdad, 10047, Iraq
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.